News & insight from CCHLE

Long periods of consecutive working days in intensive care units negatively affect the quality of care, says research co-authored by Stefan Scholtes.

In this insightful interview, Stefan Scholtes, Director of the Cambridge Centre for Health Leadership and Enterprise discusses the Centre's mission to create new types of healthcare organisations that can improve health outcomes at scale. Positioned within the Business School, the Centre focuses on implementing innovative business models that prioritise accessibility, affordability, and equity in healthcare delivery. Learn how the Centre’s unique “think-do” approach, emphasis on structural transformation, and collaborations with industry and government are reshaping the future of healthcare.…

Research at Cambridge Judge builds on previous study on cardiovascular care that involved higher treatment capacity and less-invasive procedures.

Research co-authored by Professor Stefan Scholtes of Cambridge Judge Business School highlights benefits of consistent doctor visits – both for patients and for GP workload in the NHS.

When COVID-19 travel restrictions were introduced, it sparked a trend towards remote participation in clinical assessments of new medicines’ safety and efficacy. A new study co-authored at Cambridge Judge Business School outlines a framework to assess when decentralised drug trials provide the greatest value to the system.

Increased drug supply security and reduced costs has been achieved by Civica Rx, a health care utility taking a fresh approach, says study in NEJM Catalyst authored by 2 Cambridge Judge Business School academics.

Stefan Scholtes of Cambridge Judge Business School wins Collaboration Award in the Vice Chancellor’s Awards for Research Impact and Engagement for work on the COVID pandemic. Khal Soufani of Cambridge Judge is runner-up in Established Academic award for work in circular economy.

A new Healthcare Utility Initiative to develop not-for-profit healthcare business models is launched by Cambridge Judge Business School and SSM Health.

Cambridge Judge faculty members Stefan Scholtes and Robert Wardrop are named recipients of the 2021 Sandra Dawson Research Impact Award.

Apollo Therapeutics, a life sciences company led by Cambridge Judge Business School alumnus and Fellow Dr Richard Mason (MBA 1999), completes $145 million financing.

'Second opinion' by another prescribing doctor within 30 days of an opioid prescription reduces long-term opioid use by 31%, concludes a new study led at Cambridge Judge Business School.

A new CJBS COVID-19 Tracker for India, developed by Cambridge Judge Business School and the National Institute of Economic and Social Research in India working with Health Systems Transformation Platform in India, provides forecasts of the pandemic's trajectory based on a recently developed model.